In a small study, semaglutide reduced insulin needs in people with type 1 diabetes: after 3 months, participants no longer required mealtime insulin, and after 6 months, 7 of 10 no longer needed any basal insulin
10.1038/s41366-025-01790-w 30
Why this affects your decision: the regulatory status of these peptides is genuinely fluid right now, and whats available through a legitimate medical channel today may not be the same six months from now
The scarring resulting from HS can also be physically disfiguring
In diabetes clinics across Delhi, Mumbai, and smaller cities, the same pattern keeps appearing: patients feel excited about GLP-1 medicines for weight loss and sugar control, start them with high hopes, then stop within weeks because of side effects, fear, or wrong use
Rosaly understands that the first week can bring a mix of excitement and questions, which is why she emphasizes a customized plan for every individual